Supreme Court Says No To 9 Patent Cases

By Andrew Karpan (October 3, 2022, 8:52 PM EDT) -- The U.S. Supreme Court on Monday refused to wade into nine patent cases, turning down Biogen's efforts to block its billion-dollar multiple sclerosis drug Tecfidera from facing market competition and a bid from a prolific patent filer alleging that the U.S. Patent and Trademark Office had developed a "no patents" rule specifically for him, among other matters....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Subscribers Only

Nature of Suit

Subscribers Only

Judge

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Companies

Government Agencies

Patents

Judge Analytics

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!